02.03.2020 09:12:00
|
Biotage Appoints Lars Bäckman as Interim CFO
UPPSALA, Sweden, March 2, 2020 /PRNewswire/ -- Biotage appoints Lars Bäckman as its Interim CFO. Lars has been part of Biotage's Group Management since 2007 and is currently Biotage's Chief Legal Officer (CLO). As previously announced, Erika Söderberg Johnson has decided to leave the position as CFO for new challenges. Recruitment of a permanent successor as CFO continues.
This information was submitted for publication, through the agency of the contact persons set out above, at 09:00 CET on March 2, 2020.
About Biotage
Biotage offers efficient separation technologies from analysis to industrial scale and high quality solutions for analytical chemistry from research to commercial analysis laboratories. Biotage's products are used by government authorities, academic institutions, contract research and contract manufacturing companies, pharmaceutical and food companies, among others. The company is headquartered in Uppsala and has offices in the US, UK, China, Japan, South Korea and India. Biotage has approx. 460 employees and had sales of 1 101 MSEK in 2019. Biotage is listed on NASDAQ Stockholm. Website: www.biotage.com
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/biotage/r/biotage-appoints-lars-backman-as-interim-cfo,c3050202
The following files are available for download:
https://mb.cision.com/Main/705/3050202/1204006.pdf | Press release (PDF) |
View original content:http://www.prnewswire.com/news-releases/biotage-appoints-lars-backman-as-interim-cfo-301014199.html
SOURCE Biotage
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Biotage ABShsmehr Nachrichten
22.10.24 |
Ausblick: Biotage A präsentiert Quartalsergebnisse (finanzen.net) | |
08.10.24 |
Erste Schätzungen: Biotage A legt Quartalsergebnis vor (finanzen.net) | |
15.07.24 |
Ausblick: Biotage A öffnet die Bücher zum abgelaufenen Quartal (finanzen.net) |
Analysen zu Biotage ABShsmehr Analysen
Aktien in diesem Artikel
Biotage ABShs | 13,79 | -10,63% |
Börse aktuell - Live Ticker
Asiens Börsen uneinsIn Asien finden die Börsen am Mittwoch keine gemeinsame Richtung.